| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal spinal cord dorsal column morphology | 1.45e-05 | 12 | 58 | 3 | MP:0009677 | |
| Domain | E1_4HB | 4.76e-05 | 3 | 75 | 2 | PF16191 | |
| Domain | E1_FCCH | 4.76e-05 | 3 | 75 | 2 | PF16190 | |
| Domain | UBQ-activ_enz_E1 | 4.76e-05 | 3 | 75 | 2 | IPR018075 | |
| Domain | UBA_e1_C | 4.76e-05 | 3 | 75 | 2 | SM00985 | |
| Domain | E1_4HB | 4.76e-05 | 3 | 75 | 2 | IPR032420 | |
| Domain | E1_FCCH | 4.76e-05 | 3 | 75 | 2 | IPR032418 | |
| Domain | E1_UFD | 4.76e-05 | 3 | 75 | 2 | PF09358 | |
| Domain | Ub-activating_enz_E1_C | 4.76e-05 | 3 | 75 | 2 | IPR018965 | |
| Domain | - | 9.50e-05 | 4 | 75 | 2 | 1.10.3240.10 | |
| Domain | UBIQUITIN_ACTIVAT_1 | 1.58e-04 | 5 | 75 | 2 | PS00536 | |
| Domain | Groucho_enhance | 1.58e-04 | 5 | 75 | 2 | IPR009146 | |
| Domain | UBIQUITIN_ACTIVAT_2 | 1.58e-04 | 5 | 75 | 2 | PS00865 | |
| Domain | UBA_E1_Cys | 1.58e-04 | 5 | 75 | 2 | IPR019572 | |
| Domain | TLE_N | 1.58e-04 | 5 | 75 | 2 | PF03920 | |
| Domain | UBA_e1_thiolCys | 1.58e-04 | 5 | 75 | 2 | PF10585 | |
| Domain | Groucho/TLE_N | 1.58e-04 | 5 | 75 | 2 | IPR005617 | |
| Domain | UBQ/SUMO-activ_enz_E1-like | 2.36e-04 | 6 | 75 | 2 | IPR000011 | |
| Domain | P-loop_NTPase | DHX16 RND3 RASL10A ABCB10 STARD9 MYO18A RASEF RND2 CAMTA1 SLFN14 ATAD2 | 5.44e-04 | 848 | 75 | 11 | IPR027417 |
| Domain | ThiF_NAD_FAD-bd | 7.01e-04 | 10 | 75 | 2 | IPR000594 | |
| Domain | ThiF | 7.01e-04 | 10 | 75 | 2 | PF00899 | |
| Domain | BACK | 1.81e-03 | 60 | 75 | 3 | SM00875 | |
| Domain | BACK | 1.89e-03 | 61 | 75 | 3 | PF07707 | |
| Domain | BACK | 1.89e-03 | 61 | 75 | 3 | IPR011705 | |
| Domain | Ras | 2.19e-03 | 136 | 75 | 4 | PF00071 | |
| Domain | RHO | 2.88e-03 | 20 | 75 | 2 | PS51420 | |
| Domain | - | 2.93e-03 | 746 | 75 | 9 | 3.40.50.300 | |
| Domain | Prefoldin | 3.04e-03 | 72 | 75 | 3 | IPR009053 | |
| Domain | Small_GTPase | 3.93e-03 | 160 | 75 | 4 | IPR001806 | |
| Domain | TIG | 6.86e-03 | 31 | 75 | 2 | PF01833 | |
| Domain | IPT | 7.30e-03 | 32 | 75 | 2 | IPR002909 | |
| Pubmed | 2.62e-06 | 529 | 77 | 9 | 14621295 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22551069 | ||
| Pubmed | Control of structure-specific endonucleases to maintain genome stability. | 4.84e-06 | 2 | 77 | 2 | 28327556 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 9531558 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 24938310 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 16311049 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 8645603 | ||
| Pubmed | Socius is a novel Rnd GTPase-interacting protein involved in disassembly of actin stress fibers. | 2.89e-05 | 4 | 77 | 2 | 11940653 | |
| Pubmed | Rnd1 and Rnd3 targeting to lipid raft is required for p190 RhoGAP activation. | 2.89e-05 | 4 | 77 | 2 | 22357615 | |
| Pubmed | 3.39e-05 | 407 | 77 | 7 | 12693553 | ||
| Pubmed | 4.49e-05 | 175 | 77 | 5 | 28071719 | ||
| Pubmed | Analysis of the interaction of Plexin-B1 and Plexin-B2 with Rnd family proteins. | 4.82e-05 | 5 | 77 | 2 | 29040270 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 1303260 | ||
| Pubmed | Rnd proteins function as RhoA antagonists by activating p190 RhoGAP. | 4.82e-05 | 5 | 77 | 2 | 12842009 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 8365415 | ||
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 6.39e-05 | 450 | 77 | 7 | 16751776 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX16 MROH8 NUP155 STARD9 NPEPPS RTN4 RRP12 FEN1 UBA6 ATAD2 NBR1 VARS1 | 6.68e-05 | 1425 | 77 | 12 | 30948266 |
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 21435554 | ||
| Pubmed | USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis. | 7.22e-05 | 6 | 77 | 2 | 20975683 | |
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 14732713 | ||
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 8573724 | ||
| Pubmed | The GTPase-deficient Rnd proteins are stabilized by their effectors. | 1.01e-04 | 7 | 77 | 2 | 22807448 | |
| Pubmed | A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression. | 1.01e-04 | 7 | 77 | 2 | 24024827 | |
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 11839785 | ||
| Pubmed | 1.32e-04 | 116 | 77 | 4 | 30652415 | ||
| Pubmed | Functional characterization of BRCA1 gene variants by mini-gene splicing assay. | 1.34e-04 | 8 | 77 | 2 | 24667779 | |
| Pubmed | 1.34e-04 | 8 | 77 | 2 | 16002402 | ||
| Pubmed | Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling. | 1.34e-04 | 8 | 77 | 2 | 20735826 | |
| Pubmed | 1.72e-04 | 9 | 77 | 2 | 15010812 | ||
| Pubmed | 1.72e-04 | 9 | 77 | 2 | 21989022 | ||
| Pubmed | 2.15e-04 | 10 | 77 | 2 | 12730235 | ||
| Pubmed | 2.15e-04 | 10 | 77 | 2 | 30571765 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 2.17e-04 | 732 | 77 | 8 | 34732716 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 2.63e-04 | 11 | 77 | 2 | 15499562 | |
| Pubmed | 2.63e-04 | 11 | 77 | 2 | 18786395 | ||
| Pubmed | HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer. | 2.63e-04 | 11 | 77 | 2 | 17117180 | |
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 3.15e-04 | 12 | 77 | 2 | 11266540 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.16e-04 | 774 | 77 | 8 | 15302935 | |
| Pubmed | Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function. | 3.71e-04 | 13 | 77 | 2 | 29114040 | |
| Pubmed | 3.71e-04 | 13 | 77 | 2 | 24572910 | ||
| Pubmed | 3.71e-04 | 13 | 77 | 2 | 22735158 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATXN2 GALNT11 NPEPPS KNDC1 UBA6 RASEF SYNPO ADGRV1 CAMTA1 NBR1 ANKS1A | 4.25e-04 | 1489 | 77 | 11 | 28611215 |
| Pubmed | 4.33e-04 | 14 | 77 | 2 | 17202186 | ||
| Pubmed | 4.99e-04 | 15 | 77 | 2 | 9291577 | ||
| Pubmed | 5.28e-04 | 167 | 77 | 4 | 22159717 | ||
| Pubmed | 6.30e-04 | 175 | 77 | 4 | 19851445 | ||
| Pubmed | 7.23e-04 | 18 | 77 | 2 | 33658226 | ||
| Pubmed | 7.23e-04 | 18 | 77 | 2 | 11731482 | ||
| Pubmed | New gene functions in megakaryopoiesis and platelet formation. | 7.86e-04 | 81 | 77 | 3 | 22139419 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ZC2HC1A NUP155 NPEPPS RTN4 RRP12 FEN1 MYO18A UBA6 SYNPO VARS1 | 8.53e-04 | 1367 | 77 | 10 | 32687490 |
| Pubmed | 1.09e-03 | 22 | 77 | 2 | 25107907 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.14e-03 | 942 | 77 | 8 | 31073040 | |
| Pubmed | E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. | 1.19e-03 | 23 | 77 | 2 | 19250909 | |
| Pubmed | VWF TENM4 ZC2HC1A NPEPPS CRACDL RTN4 MYO18A KNDC1 SYNPO VARS1 | 1.21e-03 | 1431 | 77 | 10 | 37142655 | |
| Pubmed | Expression of Groucho/TLE proteins during pancreas development. | 1.29e-03 | 24 | 77 | 2 | 18778483 | |
| Pubmed | Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. | 1.40e-03 | 25 | 77 | 2 | 17597759 | |
| Pubmed | 1.40e-03 | 99 | 77 | 3 | 19730683 | ||
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 1.80e-03 | 108 | 77 | 3 | 19531213 | |
| Pubmed | 1.81e-03 | 233 | 77 | 4 | 29518331 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | 1.89e-03 | 1021 | 77 | 8 | 26760575 | |
| Pubmed | 1.89e-03 | 29 | 77 | 2 | 16702430 | ||
| Pubmed | 2.18e-03 | 814 | 77 | 7 | 23251661 | ||
| GeneFamily | Ubiquitin like modifier activating enzymes | 2.94e-04 | 10 | 47 | 2 | 100 | |
| GeneFamily | Rho family GTPases | 1.22e-03 | 20 | 47 | 2 | 390 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 5.09e-03 | 134 | 47 | 3 | 861 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.37e-03 | 46 | 47 | 2 | 622 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 8.83e-07 | 187 | 77 | 6 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.03e-06 | 192 | 77 | 6 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-06 | 197 | 77 | 6 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 9.96e-06 | 165 | 77 | 5 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 179 | 77 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-05 | 179 | 77 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 179 | 77 | 5 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.60e-05 | 182 | 77 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-05 | 183 | 77 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 77 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 77 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 77 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-05 | 185 | 77 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-05 | 185 | 77 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-05 | 187 | 77 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.92e-05 | 189 | 77 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-05 | 189 | 77 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-05 | 192 | 77 | 5 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.17e-05 | 194 | 77 | 5 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.17e-05 | 194 | 77 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.17e-05 | 194 | 77 | 5 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.23e-05 | 195 | 77 | 5 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.34e-05 | 197 | 77 | 5 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 197 | 77 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 197 | 77 | 5 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 197 | 77 | 5 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.34e-05 | 197 | 77 | 5 | b1135378d768fbbe62a75747d1e8653d35252187 | |
| ToppCell | control-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.46e-05 | 199 | 77 | 5 | 50e2da35edff1aadef939cfbd4549f73c1a07717 | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.46e-05 | 199 | 77 | 5 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.88e-05 | 131 | 77 | 4 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.11e-05 | 132 | 77 | 4 | a1fda8c5287168c4f159203ed27cadfb4ce1b131 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.37e-05 | 137 | 77 | 4 | 25b5370b63644351efddb8749ef174beca0581cd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 140 | 77 | 4 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-04 | 145 | 77 | 4 | 8abbc781f5f69f039617c29a5589d7b6950c2c40 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.30e-04 | 149 | 77 | 4 | 8638b3819193d11411df58964069fec583f617f4 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L6_NP_ALM_Trh|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.30e-04 | 149 | 77 | 4 | fe9dff31a30dabd212d53d1295f9f13ff32cb217 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.33e-04 | 150 | 77 | 4 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | TCGA-Kidney|World / Sample_Type by Project: Shred V9 | 1.36e-04 | 151 | 77 | 4 | e31974c0d0a0c644205a0ee6013ab74a09d8a306 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.40e-04 | 152 | 77 | 4 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.55e-04 | 156 | 77 | 4 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 158 | 77 | 4 | 3d6295fe25e3b1fb4b6e83704c5bdbf86dc639b3 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 160 | 77 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 160 | 77 | 4 | 5cd4fbbd2ce671a8377416eff94041a111375dee | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-04 | 160 | 77 | 4 | 60fa1c717410aad7e8647703cb416cd7617cac29 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 160 | 77 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.74e-04 | 161 | 77 | 4 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 163 | 77 | 4 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 163 | 77 | 4 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-04 | 167 | 77 | 4 | 3461d14e36f09ddc6ee5549ca4797e16d3f37fcc | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.10e-04 | 169 | 77 | 4 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 2.10e-04 | 169 | 77 | 4 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 170 | 77 | 4 | 4ab2a890c8631028ee9099d2faf6091c742a317b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 170 | 77 | 4 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 171 | 77 | 4 | 6a2f88c2a62cb2f69797804e24eb1137a3e148de | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 171 | 77 | 4 | 9be3554626408bb897d1f1c43b3ab4a92651f2e2 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.20e-04 | 171 | 77 | 4 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-04 | 173 | 77 | 4 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-04 | 173 | 77 | 4 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 174 | 77 | 4 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-04 | 174 | 77 | 4 | 4a18b51501eaaeb7907e99316ba8ae15b2c7d529 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.40e-04 | 175 | 77 | 4 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 175 | 77 | 4 | f1166b567bca80dac3abe90c3dc544c831006640 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-04 | 175 | 77 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-04 | 175 | 77 | 4 | 86dfce849b2ec023a72f7e887fa681b117155e51 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|COPD / Disease state, Lineage and Cell class | 2.45e-04 | 176 | 77 | 4 | 11d867bcb4f2471b4e13a5f7dc1c24286197f26d | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.50e-04 | 177 | 77 | 4 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|World / Disease state, Lineage and Cell class | 2.50e-04 | 177 | 77 | 4 | 22b7cda748cf5e665be54ca5bae89f0c130d5e7f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 177 | 77 | 4 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(1)_24hpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 2.53e-04 | 71 | 77 | 3 | 6aa56b0daaeb5e0ae30619f9c6945c8e42899b27 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-04 | 178 | 77 | 4 | e1e96a0e3ff718ebf676a982bc63e8ced6984059 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-04 | 178 | 77 | 4 | 363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.67e-04 | 180 | 77 | 4 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-04 | 180 | 77 | 4 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-04 | 181 | 77 | 4 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 181 | 77 | 4 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.78e-04 | 182 | 77 | 4 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-04 | 182 | 77 | 4 | e6968e0bd9cef92052d04ac54e2dd746b37623f6 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-04 | 183 | 77 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 2.90e-04 | 184 | 77 | 4 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-04 | 185 | 77 | 4 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.96e-04 | 185 | 77 | 4 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.02e-04 | 186 | 77 | 4 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.02e-04 | 186 | 77 | 4 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.02e-04 | 186 | 77 | 4 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.09e-04 | 187 | 77 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-04 | 187 | 77 | 4 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.09e-04 | 187 | 77 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 188 | 77 | 4 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.15e-04 | 188 | 77 | 4 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.21e-04 | 189 | 77 | 4 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.21e-04 | 189 | 77 | 4 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.28e-04 | 190 | 77 | 4 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 190 | 77 | 4 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.28e-04 | 190 | 77 | 4 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 190 | 77 | 4 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.28e-04 | 190 | 77 | 4 | d072bb285bd34d518b958e7c9ad44739c60b359c | |
| ToppCell | Severe-Lymphoid-NK-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 3.28e-04 | 190 | 77 | 4 | e67803bf55a3f8e47a69ff1829c9100f870d7527 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 190 | 77 | 4 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.34e-04 | 191 | 77 | 4 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-04 | 191 | 77 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| Disease | cortical surface area measurement | DHX16 FOCAD RND3 DDAH2 COL24A1 NPR2 ATXN2 TLE4 PRSS55 PKHD1 CRPPA ADGRV1 ST7L PDZRN3 ANKS1A | 8.49e-07 | 1345 | 73 | 15 | EFO_0010736 |
| Disease | exfoliation syndrome | 3.61e-05 | 4 | 73 | 2 | EFO_0004235 | |
| Disease | mean platelet volume | RASL10A VWF ATXN2 NPEPPS KIF28P CAMTA1 ST7L SLFN14 ESPL1 ANKS1A | 2.01e-04 | 1020 | 73 | 10 | EFO_0004584 |
| Disease | immature platelet measurement | 2.21e-04 | 119 | 73 | 4 | EFO_0803541 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 2.47e-04 | 49 | 73 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | neuroimaging measurement | RND3 COL24A1 SZT2 ATXN2 TLE4 PKHD1 CAMTA1 ST7L PDZRN3 ANKS1A | 2.93e-04 | 1069 | 73 | 10 | EFO_0004346 |
| Disease | anthropometric measurement | 8.13e-04 | 168 | 73 | 4 | EFO_0004302 | |
| Disease | lymphocyte count | USP50 FOCAD TENM4 ZC2HC1A ATXN2 TLE4 RTN4 ASB3 HSF2 VARS1 PTH1R | 9.05e-04 | 1464 | 73 | 11 | EFO_0004587 |
| Disease | factor VIII measurement, Ischemic stroke | 1.00e-03 | 19 | 73 | 2 | EFO_0004630, HP_0002140 | |
| Disease | reaction time measurement | 1.21e-03 | 658 | 73 | 7 | EFO_0008393 | |
| Disease | open-angle glaucoma | 1.31e-03 | 191 | 73 | 4 | EFO_0004190 | |
| Disease | obsolete_red blood cell distribution width | 1.72e-03 | 1347 | 73 | 10 | EFO_0005192 | |
| Disease | platelet crit | 2.40e-03 | 952 | 73 | 8 | EFO_0007985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YIVLASAEENACSLP | 246 | Q6PI77 | |
| ASYLADADCLPSAAQ | 1441 | Q9Y6Y1 | |
| AELYAPASAAAADLA | 56 | Q96KE9 | |
| LASAYASPQLAEESC | 5956 | Q8WXG9 | |
| SCSIAENIAYGADDP | 581 | Q9NRK6 | |
| LEGACSEYLAPLSAV | 71 | P20594 | |
| CAAQDPEDLCTFAYI | 1011 | Q92625 | |
| DSDISCPLLESDLAY | 736 | Q6PL18 | |
| CPLLESDLAYSDDDV | 741 | Q6PL18 | |
| APEADYLEACVVSVL | 586 | O60231 | |
| CDADPSALANYVVAL | 21 | Q9P2N5 | |
| ISADCTDADYLGIPV | 626 | Q9UPQ7 | |
| SYVDEDCDSLALCDP | 406 | Q8IZ41 | |
| RPALYLAALDCAEET | 91 | O00391 | |
| VSPSADGCLDYSLER | 191 | A4D126 | |
| TYSPKCDLVLDAAHE | 296 | Q99700 | |
| AAEEKCLASTAYAPE | 396 | Q08397 | |
| QLAEPYDTFVCDSAA | 516 | Q86UP0 | |
| EAYVCALSEFVDPSS | 126 | Q9HA72 | |
| APSCDRLEDLASLVY | 401 | Q92614 | |
| CPVIDIISADTLAYS | 271 | Q8NCW6 | |
| EASLDSVLCYDPVAA | 411 | O60662 | |
| EPCGFEATYLELASA | 31 | Q9BRT3 | |
| FCDYEPLLELSCSDT | 176 | Q8NGE2 | |
| NCADIDIITASYAPE | 96 | A6NEC2 | |
| PCAYDSDSESVDLEL | 16 | Q9H579 | |
| LDSACSAITYTIPVD | 556 | Q0VG06 | |
| VADFSYPAESSSCLD | 206 | Q6NV74 | |
| YSNAVAEEAACPVSA | 141 | Q96JZ2 | |
| DICPLLYSTDDAICS | 861 | O75694 | |
| LDYVTELTGADCDPV | 351 | Q9BRP4 | |
| TLTLECEAYAIPSAS | 2691 | Q96RW7 | |
| LLSSGADPDLYCNED | 231 | Q9Y575 | |
| ELAELACDGYLVSTP | 76 | Q14674 | |
| PYLDAPSEAEASCAA | 151 | P39748 | |
| SLPTAEIDCSLAEYI | 226 | Q9NQC8 | |
| ESCAAAEALTAPEDA | 341 | Q6ZUS6 | |
| AYLCLDSVLVAEDGA | 481 | Q76NI1 | |
| PYASLTLPDDAAADC | 206 | O95865 | |
| NCADIDIITASYAPE | 96 | P55786 | |
| TALVAAVSPADICYE | 326 | B7ZC32 | |
| AVSPADICYEETLST | 331 | B7ZC32 | |
| DVEDVDLSVPGSCYL | 746 | Q5VW36 | |
| SYPDSDAVLICFDIS | 91 | P61587 | |
| ASEATLFYLCELAPA | 511 | Q03933 | |
| ALQETEAPYISIACD | 686 | Q9NQC3 | |
| TDAFVLVYDICSPDS | 86 | Q92737 | |
| AAVCLSEDLYPDINV | 456 | Q6ZW31 | |
| SYADTELIPAACGAT | 101 | P26640 | |
| APLPSDDYAADESCA | 2006 | Q5T011 | |
| SETAYEEATCAQALP | 766 | P0C7P3 | |
| LDADELISAACVVYA | 306 | Q8IYX1 | |
| SASSEDYIIILPECF | 726 | Q14596 | |
| PDGSYRCLALEAEES | 26 | Q8N3V7 | |
| AEGDSLVCYNPLLDS | 436 | Q9NVX7 | |
| SALDLPSACDIRDYV | 16 | Q8IYI0 | |
| ATPLLYALAAEAEAA | 111 | Q2M3G4 | |
| SCYSDDLDVCILPNA | 3286 | P08F94 | |
| LVDLAGSERADPSYC | 251 | Q9P2P6 | |
| APCADEAAISKLYST | 761 | Q5JTH9 | |
| QLDIIPSAEASADYC | 221 | Q17RW2 | |
| DALVSAFCLEAVSPD | 176 | P11086 | |
| ATVYCIPFAEEDLSA | 766 | A0AVT1 | |
| YPDSDAVLICFDISR | 76 | P52198 | |
| GTELCDESYPALLTD | 811 | Q7Z392 | |
| SLSYPDEECNEACLE | 671 | P04275 | |
| SADVEAAASYPEALA | 156 | Q96MW7 | |
| ASAAASEDAPYPVCT | 586 | P41226 | |
| CPVLSSAYALVDADD | 16 | Q03431 | |
| AELTSSAPACYALAI | 571 | Q04727 | |
| LDLTDPYTISALASC | 86 | A6NFA1 | |
| SLAVCADGELYVADL | 1541 | Q6N022 | |
| SAEADACPSVLYSEV | 166 | Q8N816 | |
| DDISLPKSAAICYTA | 356 | Q8TDW4 | |
| LPSDCSEVATAFAYL | 86 | Q70EL3 | |
| LDAPVLSQAECEASY | 161 | P07478 | |
| AAHCLYSEELFPEEL | 106 | Q6UWB4 | |
| ESYIARPDGDCASSL | 266 | Q96GY0 | |
| LCFELDYEPAHISLD | 301 | Q9UDY6 | |
| AELTSSAPACYALAV | 541 | Q04725 | |
| ASLLAAYDACATPKE | 501 | Q96NY9 |